T/SBX 055-2022
Test methods for tumorigenicity of stem cell therapy products (English Version)

Standard No.

T/SBX 055-2022

Language

Chinese, Available in English version

Release Date

2022

Published By

Group Standards of the People's Republic of China

Latest

T/SBX 055-2022

Scope

This document proposes the test principles, test conditions, main reagents, equipment and test procedures for tumorigenicity tests of stem cell (including embryonic stem cells, adult stem cells, induced pluripotent stem cells, etc.) therapeutic products.

T/SBX 055-2022 history

• 2022 T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products